Clinical trials · Missouri
Hereditary Angioedema - Type 2 clinical trials in Missouri
We’re tracking 2 recruiting hereditary angioedema - type 2 studies with a site in Missouri — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Missouri
- NCT07001280Recruiting
Garadacimab for hereditary angioedema (HAE)
This study looks at how well a drug called garadacimab works and how safe it is for people with hereditary angioedema (HAE), a condition that causes sudden swelling. It tests the drug in people who are starting it for the first time as part of their regular care.
St Louis, MissouriAges 12 years+ - NCT06679881RecruitingPhase 3
Preventing swelling attacks with oral deucrictibant for HAE
This study tests a long-term daily pill to prevent swelling attacks in people with hereditary angioedema (HAE). The pill, called deucrictibant, is designed to block a protein involved in causing attacks. It's for adolescents and adults who want to reduce how often swelling episodes occur.
St Louis, MissouriAges 12 years+
Hereditary Angioedema - Type 2 trials by city in Missouri
Where these studies are running in Missouri
Institutions with a site for the recruiting hereditary angioedema - type 2 studies listed above.
- Study Site
- Washington University in St. Louis
What taking part in a hereditary angioedema - type 2 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Hereditary Angioedema - Type 2 trials in other states
Common questions
- Are there hereditary angioedema - type 2 clinical trials in Missouri?
- Yes. We're currently tracking 2 recruiting hereditary angioedema - type 2 studies with a site in Missouri, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hereditary angioedema - type 2 study in Missouri?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Missouri to take part?
- Not necessarily. These studies have a site in Missouri, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hereditary angioedema - type 2 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hereditary angioedema - type 2 studies open in Missouri regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.